Susquehanna International Group, LLP Neoleukin Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.4 - $0.55 $10,622 - $14,605	26,556 New	26,556 $13,000
Q2 2022 Aug 15, 2022	BUY	$0.92 - $2.25 $38,513 - $94,191	41,863 Added 140.22%	71,719 $74,000
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.75 $11,699 - $19,499	2,516 Added 9.2%	29,856 $144,000
Q3 2021 Nov 15, 2021	SELL	$6.05 - $9.66 $88,832 - $141,837	-14,683 Reduced 34.94%	27,340 $198,000
Q2 2021 Aug 11, 2021	BUY	$9.23 - $13.12 $217,892 - $309,723	23,607 Added 128.19%	42,023 $388,000
Q1 2021 May 17, 2021	BUY	$11.26 - $15.78 $93,435 - $130,942	8,298 Added 82.01%	18,416 $227,000
Q4 2020 Feb 16, 2021	SELL	$10.17 - $14.56 $28,404 - $40,666	-2,793 Reduced 21.63%	10,118 $143,000
Q3 2020 Nov 16, 2020	BUY	$9.68 - $17.01 $124,978 - $219,616	12,911 New	12,911 $155,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.